Importantly, CaMKII phosphorylation of RyR2 at serine 2814 is evident to prevent the latent arrhythmic potential of RyR2 mutations in CPVT-1 indicating antiarrhythmic effects [73,175]. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia 1.